Literature DB >> 17517864

Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.

Warren L Simmons1, Kevin Dybvig.   

Abstract

The length of the tandem repeat region of the Vsa protein of Mycoplasma pulmonis has previously been shown to modulate the susceptibility of mycoplasmas to killing by complement: cells that produce a short form of the Vsa protein are highly sensitive, and cells producing the long Vsa protein are resistant. In contrast to their differing susceptibilities to complement, the mycoplasmas were highly sensitive to gramicidin irrespective of the length of the Vsa protein produced. We show here that when encased within a biofilm, cells of M. pulmonis producing a short form of the Vsa protein were more resistant to complement and gramicidin than mycoplasmas that were dispersed. The resistance appeared to be localized to those mycoplasmas within tower structures of the biofilms. Biofilm formation may be a mechanism that protects mycoplasmas from host immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517864      PMCID: PMC1951995          DOI: 10.1128/IAI.00440-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

3.  Susceptibility of biofilm cells of Pseudomonas aeruginosa to bactericidal actions of whole blood and serum.

Authors:  H Anwar; J L Strap; J W Costerton
Journal:  FEMS Microbiol Lett       Date:  1992-05-01       Impact factor: 2.742

4.  Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.

Authors:  Miguel A Campos; Miguel A Vargas; Verónica Regueiro; Catalina M Llompart; Sebastián Albertí; José A Bengoechea
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.

Authors:  Warren L Simmons; Jeffrey R Bolland; James M Daubenspeck; Kevin Dybvig
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

6.  Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.

Authors:  Warren L Simmons; Amy M Denison; Kevin Dybvig
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Cytopathic effects of Mycoplasma pulmonis in vivo and in vitro.

Authors:  C T Stadtländer; H L Watson; J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system.

Authors:  Cuong Vuong; Jovanka M Voyich; Elizabeth R Fischer; Kevin R Braughton; Adeline R Whitney; Frank R DeLeo; Michael Otto
Journal:  Cell Microbiol       Date:  2004-03       Impact factor: 3.715

10.  Complement activation by Pseudomonas aeruginosa biofilms.

Authors:  E T Jensen; A Kharazmi; P Garred; G Kronborg; A Fomsgaard; T E Mollnes; N Høiby
Journal:  Microb Pathog       Date:  1993-11       Impact factor: 3.738

View more
  15 in total

1.  In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.

Authors:  Ji-Hoi Moon; Eun-Young Jang; Kyu Sang Shim; Jin-Yong Lee
Journal:  J Microbiol       Date:  2015-05-03       Impact factor: 3.422

2.  Catalase Enhances Growth and Biofilm Production of Mycoplasma pneumoniae.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Curr Microbiol       Date:  2015-04-18       Impact factor: 2.188

3.  Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms.

Authors:  Warren L Simmons; James M Daubenspeck; John D Osborne; Mitchell F Balish; Ken B Waites; Kevin Dybvig
Journal:  Microbiology       Date:  2013-02-14       Impact factor: 2.777

4.  Mycoplasma polysaccharide protects against complement.

Authors:  Jeffrey R Bolland; Warren L Simmons; James M Daubenspeck; Kevin Dybvig
Journal:  Microbiology       Date:  2012-04-13       Impact factor: 2.777

5.  Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model.

Authors:  Qingli Kong; Janet M Beanan; Ruth Olson; Ulrike Macdonald; Alyssa S Shon; Daniel J Metzger; Alexander O Pomakov; Thomas A Russo
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

6.  Mycoplasma biofilms ex vivo and in vivo.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2009-06       Impact factor: 2.742

7.  Identification of exopolysaccharide-deficient mutants of Mycoplasma pulmonis.

Authors:  James M Daubenspeck; Jeffrey R Bolland; Wenyi Luo; Warren L Simmons; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2009-05-07       Impact factor: 3.501

8.  Antibacterial effects of N-acetylcysteine against endodontic pathogens.

Authors:  Ji-Hoi Moon; Young-Suk Choi; Hyeon-Woo Lee; Jung Sun Heo; Seok Woo Chang; Jin-Yong Lee
Journal:  J Microbiol       Date:  2016-04-01       Impact factor: 3.422

9.  Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

Authors:  Katherine Pandelidis; Amanda McCarthy; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

10.  Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae.

Authors:  Mirian Domenech; Elisa Ramos-Sevillano; Ernesto García; Miriam Moscoso; Jose Yuste
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.